| Cat. No. | Product Name | Information | 
            
                
            	| PC-38883 | Goflikicept Anti-IL-1B fusion protein | Goflikicept (RPH-104) is a heterodimeric fusion protein containing IL-1R1 and IL-1RAcP linked to immunoglobulin heavy chains and is highly selectively binds IL-1B, affecting IL-1B signalling pathways, inhibits widespread inflammation. | 
            
                
            	| PC-38856 | Batiraxcept AXL Fc fusion | Batiraxcept (AVB‐S6‐500, AVB-500) is a first-in-class Fc fusion protein of the extracellular domain of AXL that binds the GAS6 ligand thereby inhibiting AXL signaling. | 
            
                
            	| PC-38865 | Trebananib Ang1 and Ang2 peptibody | Trebananib (AMG 386) is a first-in-class peptide-Fc fusion protein (peptibody) that inhibits angiogenesis by preventing the interaction of angiopoietin-1 (Ang1) and Ang2 with their receptor, Tie2. | 
            
                
            	| PC-38829 | Lerodalcibep Anti-PCSK9 fusion protein | LIB003 (Lerodalcibep) is an engineered PCSK9 protein inhibitor for the treatment of hypercholesterolemia. Anti-(human proprotein convertase subtilisin/kexin type 9), derived from human tenth fibronectin type III domain, fused via peptidyl linker (97GSGSGS102) to human serum albumin (103-687), variant (C34>A136), produced in Chinese hamster ovary (CHO) cells. |